184 related articles for article (PubMed ID: 9870249)
1. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
Nalesnik MA; Starzl TE
Transplant Sci; 1994 Sep; 4(1):61-79. PubMed ID: 7804700
[TBL] [Abstract][Full Text] [Related]
2. Recent advancements in hematopoietic stem cell transplantation in Taiwan.
Li CC; Tsai XC; Huang WH; Wang TF
Tzu Chi Med J; 2024; 36(2):127-135. PubMed ID: 38645784
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection: the micro and macro worlds.
Huang W; Bai L; Tang H
Virol J; 2023 Oct; 20(1):220. PubMed ID: 37784180
[TBL] [Abstract][Full Text] [Related]
4. Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database.
Lee CC; Hsu TC; Kuo CC; Liu MA; Abdelfattah AM; Chang CN; Yao M; Li CC; Wu KH; Chen TC; Gau JP; Wang PN; Liu YC; Chiou LW; Lee MY; Li SS; Chao TY; Jou ST; Chang HH
Oncologist; 2021 Nov; 26(11):e2034-e2041. PubMed ID: 34506688
[TBL] [Abstract][Full Text] [Related]
5. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.
Gibson TM; Engels EA; Clarke CA; Lynch CF; Weisenburger DD; Morton LM
Am J Hematol; 2014 Jul; 89(7):714-20. PubMed ID: 24753070
[TBL] [Abstract][Full Text] [Related]
6. EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.
Macedo C; Webber SA; Donnenberg AD; Popescu I; Hua Y; Green M; Rowe D; Smith L; Brooks MM; Metes D
J Immunol; 2011 May; 186(10):5854-62. PubMed ID: 21460204
[TBL] [Abstract][Full Text] [Related]
7. CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.
Lin X; Gudgeon NH; Hui EP; Jia H; Qun X; Taylor GS; Barnardo MC; Lin CK; Rickinson AB; Chan AT
Cancer Immunol Immunother; 2008 Jul; 57(7):963-75. PubMed ID: 18094968
[TBL] [Abstract][Full Text] [Related]
8. Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.
Gudgeon NH; Taylor GS; Long HM; Haigh TA; Rickinson AB
J Virol; 2005 May; 79(9):5477-88. PubMed ID: 15827162
[TBL] [Abstract][Full Text] [Related]
9. Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood.
Bergallo M; Merlino C; Daniele R; Sinesi F; Fumagalli M; Ponzi AN; Cavallo R
Mol Biotechnol; 2004 Jul; 27(3):187-96. PubMed ID: 15247492
[TBL] [Abstract][Full Text] [Related]
10. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.
Taylor GS; Haigh TA; Gudgeon NH; Phelps RJ; Lee SP; Steven NM; Rickinson AB
J Virol; 2004 Jan; 78(2):768-78. PubMed ID: 14694109
[TBL] [Abstract][Full Text] [Related]
11. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.
Midgley RS; Bell AI; McGeoch DJ; Rickinson AB
J Virol; 2003 Nov; 77(21):11517-30. PubMed ID: 14557637
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.
Meru N; Davison S; Whitehead L; Jung A; Mutimer D; Rooney N; Kelly D; Niedobitek G
Mol Pathol; 2001 Aug; 54(4):264-9. PubMed ID: 11477143
[TBL] [Abstract][Full Text] [Related]
13. Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.
Ohga S; Kubo E; Nomura A; Takada H; Suga N; Ishii E; Suminoe A; Inamitsu T; Matsuzaki A; Kasuga N; Hara T
Int J Hematol; 2001 Apr; 73(3):323-6. PubMed ID: 11345197
[TBL] [Abstract][Full Text] [Related]
14. Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr virus exclusively in the immunoglobulin D-negative B-cell compartment.
Rose C; Green M; Webber S; Ellis D; Reyes J; Rowe D
J Clin Microbiol; 2001 Apr; 39(4):1407-15. PubMed ID: 11283064
[TBL] [Abstract][Full Text] [Related]
15. The role of EBV in post-transplant malignancies: a review.
Hopwood P; Crawford DH
J Clin Pathol; 2000 Apr; 53(4):248-54. PubMed ID: 10823119
[No Abstract] [Full Text] [Related]
16. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).
Nalesnik MA
Springer Semin Immunopathol; 1998; 20(3-4):325-42. PubMed ID: 9870249
[No Abstract] [Full Text] [Related]
17. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
[No Abstract] [Full Text] [Related]
18. Post-transplant lymphoproliferative disorder.
Basgoz N; Preiksaitis JK
Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
Rustgi VK
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
